Oxibiota 31.25 Billion CFU Capsule

Each Oxibiota Capsule contains a blend of multi-strain probiotics that includes Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus bulgaricus, Streptococcus thermophilus etc.

 

Probiotics may beneficially affect the host upon ingestion by improving the balance of the intestinal microbiota; and exhibit a mutualistic relationship with the human body to protect the host against potential invasions by pathogens, reduce symptoms of lactose intolerance, produce short chain fatty acid in intestine, reduce gastrointestinal inflammation and stimulate immunity etc.

 

The multi-strain probiotics used in Oxibiota Capsule are found to be effective in the following gastrointestinal diseases –

  • Irritable Bowel Syndrome (IBS)
  • Inflammatory Bowel Diseases (IBD)
  • Ulcerative Colitis (UC)
  • Lactose Intolerance
  • Indigestion
  • Constipation
  • Diarrhea
  • Poor Immunity
  • Gastrointestinal flora balance
Category:

Description

COMPOSITION:

Each Oxibiota Capsule contains a blend of 31.25 Billion CFU multi-strain probiotics. Probiotic combination used in Oxibiota Capsule includes Lactobacillus acidophilus 5 billion (25 mg) + Lactobacillus plantarum 10 billion (50 mg) + Lactobacillus paracasei 4 billion (20 mg) + Bifidobacterium lactis 10 billion (50 mg) + Bifidobacterium longum 0.5 billion (5 mg) + Bifidobacterium infantis 0.5 billion (10 mg) + Lactobacillus bulgaricus 0.25 billion (5 mg) + Streptococcus thermophilus 1 billion (5 mg) etc.

 

DIRECTIONS FOR USE:

1 Oxibiota Capsule 2 – 3 times daily or as directed by the physician 

 

COMMERCIAL PACK:
Box contains 30 Capsules in alu-alu blister pack.

MANUFACTURED BY:

Neoventis Biotech, Herbal and Nutraceuticals (NBN)

Valuka, Mymensingh, Bangladesh.